Global Pharmaceutical Suppositories Market is valued approximately at USD 1.69 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 5.7% over the forecast period ...
Massachusetts gastrointestinal disease firm, Cristcot, has announced results from its Phase III trial examining its hydrocortisone suppository and applicator for ulcerative colitis (UC), finding ...
LGM Pharma invests $6 mn in US drug manufacturing facility to increase capacity for liquid, suspension, semi-solid & suppository drug products: Boca Raton, Florida Saturday, March ...
The expansion will increase capacity for liquid, suspension, semi-solid, and suppository drug products, addressing the rising demand for reliable U.S.-based production. This investment comes as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results